Related references
Note: Only part of the references are listed.Human Papillomavirus (HPV) 16 and 18/45 Genotyping-Directed Follow-up of Women With Messenger RNA HPV-Positive, Cytology-Negative Cervical Screening Test Results
Min Han et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2020)
Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis
Marc Arbyn et al.
LANCET GLOBAL HEALTH (2020)
2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors
Rebecca B. Perkins et al.
JOURNAL OF LOWER GENITAL TRACT DISEASE (2020)
Prevalence of HPV-16/18 genotypes and immediate histopathologic correlation results in a Chinese population with negative cytology and positive high-risk HPV testing
Xiang Tao et al.
CANCER CYTOPATHOLOGY (2019)
Glandular cell abnormalities in cervical cytology: What has changed in this decade and what has not?
Neeta Kumar et al.
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2019)
Clinical significance of genotyping for human papillomavirus (HPV) 16 18/45 combined with cytology in cervical exfoliated cells in HPV oncogenic mRNA-positive women
Jiajian Wang et al.
GYNECOLOGIC ONCOLOGY (2019)
Glandular Cell Abnormalities on SurePath Preparations: A Retrospective Review with Cytology-Histology Correlations
Gabor Fischer et al.
ACTA CYTOLOGICA (2018)
Comparison of Unsatisfactory Rates and Detection of Abnormal Cervical Cytology Between Conventional Papanicolaou Smear and Liquid-Based Cytology (Sure Path®)
Saroot Kituncharoen et al.
Asian Pacific Journal of Cancer Prevention (2016)
A Comparative Study of Conventional and Liquid-Based Cervical Cytology
Mehmet BUDAK et al.
Ginekologia Polska (2016)
A review of the clinical performance of the Aptima HPV assay
Juliane Haedicke et al.
JOURNAL OF CLINICAL VIROLOGY (2016)
Human Papillomavirus Assays and Cytology in Primary Cervical Screening of Women Aged 30 Years and Above
Matejka Rebolj et al.
PLOS ONE (2016)
Human Papillomavirus Oncogenic mRNA Testing for Cervical Cancer Screening Baseline and Longitudinal Results From the CLEAR Study
Jennifer L. Reid et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2015)
Head-to-Head Comparison of the RNA-Based Aptima Human Papillomavirus (HPV) Assay and the DNA-Based Hybrid Capture 2 HPV Test in a Routine Screening Population of Women Aged 30 to 60 Years in Germany
Thomas Iftner et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2015)
Comparison of Human Papillomavirus Detection by Aptima HPV and cobas HPV Tests in a Population of Women Referred for Colposcopy following Detection of Atypical Squamous Cells of Undetermined Significance by Pap Cytology
Philip E. Castle et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2015)
HPV E6/E7 mRNA versus HPV DNA biomarker in cervical cancer screening of a group of Macedonian women
Sotirija Duvlis et al.
JOURNAL OF MEDICAL VIROLOGY (2015)
Triage of Women With Minor Abnormal Cervical Cytology Meta-Analysis of the Accuracy of an Assay Targeting Messenger Ribonucleic Acid of 5 High-Risk Human Papillomavirus Types
Maria Benevolo et al.
CANCER CYTOPATHOLOGY (2014)
Comparison of cervical cancer screening strategies incorporating different combinations of cytology, HPV testing, and genotyping for HPV 16/18: results from the ATHENA HPV study
J. Thomas Cox et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2013)
Comparing the performance of six human papillomavirus tests in a screening population
J. Cuzick et al.
BRITISH JOURNAL OF CANCER (2013)
Triage of Women With Minor Abnormal Cervical Cytology
Freija Verdoodt et al.
CANCER CYTOPATHOLOGY (2013)
The APTIMA HPV assay versus the hybrid capture 2 test in triage of women with ASC-US or LSIL cervical cytology: A meta-analysis of the diagnostic accuracy
Marc Arbyn et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Primary Cervical Cancer Screening and Triage Using an mRNA Human Papillomavirus Assay and Visual Inspection
Lucybeth Nieves et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2013)
Significance of HPV-58 Infection in Women Who Are HPV-Positive, Cytology-Negative and Living in a Country with a High Prevalence of HPV-58 Infection
Joon Seon Song et al.
PLOS ONE (2013)
Biochemical and Functional Interactions of Human Papillomavirus Proteins with Polycomb Group Proteins
Margaret E. McLaughlin-Drubin et al.
VIRUSES-BASEL (2013)
High-Risk Human Papillomavirus (hrHPV) E6/E7 mRNA Testing by PreTect HPV-Proofer for Detection of Cervical High-Grade Intraepithelial Neoplasia and Cancer among hrHPV DNA-Positive Women with Normal Cytology
D. C. Rijkaart et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2012)
Comparison of Seven Tests for High-Grade Cervical Intraepithelial Neoplasia in Women with Abnormal Smears: the Predictors 2 Study
Anne Szarewski et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2012)
Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial
Dorien C. Rijkaart et al.
LANCET ONCOLOGY (2012)
Evidence Regarding Human Papillomavirus Testing in Secondary Prevention of Cervical Cancer
Marc Arbyn et al.
VACCINE (2012)
Glandular neoplasia and borderline endocervical reporting rates before and after conversion to the SurePathTM liquid-based cytology (LBC) system
C. Burnley et al.
DIAGNOSTIC CYTOPATHOLOGY (2011)
Comparison of different commercial methods for HPV detection in follow-up cytology after ASCUS/LSIL, prediction of CIN2-3 in follow up biopsies and spontaneous regression of CIN2-3
Irene T. Ovestad et al.
GYNECOLOGIC ONCOLOGY (2011)
EUROGIN 2010 roadmap on cervical cancer prevention
Silvia Franceschi et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Sensitivity, Specificity, and Clinical Value of Human Papillomavirus (HPV) E6/E7 mRNA Assay as a Triage Test for Cervical Cytology and HPV DNA Test
Maria Benevolo et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2011)
Clinical Performance of the PreTect HPV-Proofer E6/E7 mRNA Assay in Comparison with That of the Hybrid Capture 2 Test for Identification of Women at Risk of Cervical Cancer
Samuel Ratnam et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2010)
Practice Improvement in Cervical Screening and Management (PICSM): Symposium on Management of Cervical Abnormalities in Adolescents and Young Women
Anna-Barbara Moscicki et al.
JOURNAL OF LOWER GENITAL TRACT DISEASE (2010)
Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study
Silvia de Sanjose et al.
LANCET ONCOLOGY (2010)
Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial
Guglielmo Ronco et al.
LANCET ONCOLOGY (2010)
Human papillomavirus oncoproteins: pathways to transformation
Cary A. Moody et al.
NATURE REVIEWS CANCER (2010)
HPV testing in combination with liquid-based cytology in primary cervical screening (ARTISTIC): a randomised controlled trial
Henry C. Kitchener et al.
LANCET ONCOLOGY (2009)
Type-dependent integration frequency of human papillomavirus genomes in cervical lesions
Svetlana Vinokurova et al.
CANCER RESEARCH (2008)
Heterogeneity in CIN3 diagnosis
Mark Shiffman et al.
LANCET ONCOLOGY (2008)
Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study
Margaret R. E. McCredie et al.
LANCET ONCOLOGY (2008)
Human papillomavirus and papanicolaou tests to screen for cervical cancer
Pontus Naucler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Comparison of conventional Papanicolaou smear and SurePath® liquid-based cytology in the Copenhagen population screening programme for cervical cancer
B. Kirschner et al.
CYTOPATHOLOGY (2006)
Share Paper
